ClinicalTrials.gg
Drug

Aminolevulinic Acid clinical trials

Also written 5-ALA, Levulan and Gleolan.

Includes 16 studies of Oral Aminolevulinic Acid Hydrochloride, 8 studies of BF-200 ALA and 1 study of Aminolevulinic acid phosphate.

studies test it
114
open now
16
in phase 3
17
first study started
1993

How each study uses Aminolevulinic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Aminolevulinic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Dec 1999 · LEVULAN · NDA 020965 (FDA, Drugs@FDA)
European Union
7 Sept 2007 · Gliolan · EMEA/H/C/000744 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Aminolevulinic Acid
22
Levulan Kerastick
15
ALA
13
5-aminolevulinic acid
12
aminolevulinic acid hydrochloride
9

Brand

Levulan
10
Gleolan
6

Other names

5-ALA
18
Ameluz
4
Gliolan®
2

Studies by the year they started

113 studies that test it; most in 2014 (10); 1 more planned to start later

Studies that test Aminolevulinic Acid, by start year
YearStudies
19931
19971
19992
20001
20051
20061
20074
20085
20096
20103
20116
20127
20134
201410
20158
20165
20176
20182
20195
20204
20218
20222
20233
20247
20255
20266

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
29
Phase 2
53
Phase 3
17
Phase 4
11
No phase
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 84

DUSA Pharmaceuticals, Inc. (10) · Biofrontera Bioscience GmbH (5) · Joint Authority for Päijät-Häme Social and Health Care (4) · Roswell Park Cancer Institute (4) · Universität Münster (3) · The Center for Clinical and Cosmetic Research (3) · University of California, Davis (3) · photonamic GmbH & Co. KG (3)

Often tested with

Tested in the same studies.

Methyl aminolevulinate (5) · Photodynamic Therapy (2) · Hexaminolevulinate hydrochloride (1) · HhAntag691 (1) · Carmustine, poliferprosan 20 drug combination (1) · Iron (1) · Phototherapy (1) · Methyl aminolevulinate hydrochloride (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test Aminolevulinic Acid.

Studies

Open first, then newest update. How each study uses Aminolevulinic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 114

See all 114 studies that test Aminolevulinic Acid →

Given beside what is tested · 5 — Aminolevulinic Acid is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Aminolevulinic Acid

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Aminolevulinic Acid · ClinicalTrials.gg INT006952

  • MeSH (NLM) D000622Aminolevulinic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 88755TAZ87AMINOLEVULINIC ACIDConfirmed FDA, NLM, Wikidata
  • RxNorm 683Confirmed FDA, Wikidata
  • Wikidata Q238474aminolevulinic acidConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C234Aminolevulinic AcidOne source FDA
  • DrugBank DB00855One source Wikidata

Also registered as aminolevulinic acid hydrochloride (UNII V35KBM8JGR · RxNorm 261715).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.